Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

The World Health Organization has released new guidelines which, for the first time, recommend the use of an injectable form ...

A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...

For some people, HIV feels like something that happens to “other people.” It’s a distant issue — something for a different ...

New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

The loss of federal funding from the Centers for Disease Control comes as Memphis health officials face rising rates of new ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Increasing the use of Apretude among Black women requires not only expanding awareness of the long-acting PrEP regimen in ...

Cuts to U.S. foreign aid will endanger HIV treatment and prevention services globally and are likely to reverse decades of ...

Strategies that address population-specific concerns about medical mistrust and employ operational tactics, including staff ...

The Department of Justice said it sent more than 20 subpoenas to doctors and clinics involved with transgender medical ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...